Virologists doubt the data on the universal antibody from COVID

The discovery by Chinese scientists of 35B5 antibodies to CORONAVIRUS, which they claim is universal for use against all strains of the infection, is not applicable as a vaccine, but is suitable for treatment in the early stages of the disease. This was stated in a conversation with RBC by Sergei Voznesensky, Associate Professor of the Department of Infectious Diseases at the People's Friendship University of RUSSIA.

“These are means for treating patients in the early stages. Most often, these drugs are prescribed in parenteral (injectable.) Forms. If a virus enters the human body, taking a monoclonal preparation of neutralizing antibodies neutralizes the viral particles, they will not cause the disease, ”he said.

Voznesensky also pointed out that a regimen of two monoclonal neutralizing drugs was already presented in September in the WHO recommendations. it was advised to use it in the early stages in mild and moderate patients who have a high risk of severe disease. Moreover, the scientist continued, in November such a treatment regimen was also registered in Russia.

Medicines for intravenous use based on the immune cells of an ill person have existed since 2020, DIRECTOR of the Center for the Global Virological Network Konstantin Chumakov said in an interview with RBC. He also pointed out that so far, science has not discovered a way to create an antibody-based vaccine.